By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
DenyAccept

Investing in companies shaping the future of

neruotechnology

medicine

Founded by two prominent neurosurgeons in academic practice and a veteran of capital accrual for investment opportunities, our mission is to identify and invest in unique, well positioned companies focused on scientific breakthroughs.

Read more about METIS
Co-Founder Brian A. Sidman

"METIS was the first investment group to truly believe in the work that we were doing, providing us with the seed investment to go about building our product and brand.

David Putrino | Chief Strategy Officer, Precision Recovery, Inc
Fluid Biomed — Big investments that break new ground
Read More

Our Investments

Precision Recovery

Investing in a world where preventable second strokes no longer occur.

Fluid Biomed

Fluid Biomed is developing the world’s first bio-resorbable polymer-based stent to cure brain aneurysms.

Proprio

Proprio is a technology company modernizing the way we predict, perform, and perfect surgery through the combination of physician expertise and immersive, intelligent technology.
View All
Home
About us
Portfolio
Contact us